Evidence map›Paper›PMID 35688916›Full record

ArticleScientific reports2022

Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex.

Shinnyi Chou, Tejis Ranganath, Kenneth N Fish, David A Lewis, Robert A Sweet

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Neuroprotective Role of Cannabinoid CBMolecular neurobiology · 2026
    Article
  9. Article
  10. FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  11. Review
  12. Review
  13. Motor-Related Neural Dynamics are Modulated by Regular Cannabis Use Among People with HIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  14. Review
  15. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  16. Chronic ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Heteromers Formed by GPR55 and Either Cannabinoid CBInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shinnyi ChouDepartment of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA.
Tejis RanganathDepartment of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA.
Kenneth N FishDepartment of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA.
David A LewisDepartment of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA.
Robert A SweetDepartment of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA. sweetra@upmc.edu.
University of Pittsburgh Medical Center · US

Funding

Statistics and Data Management CoreP50MH103204 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEWIS, DAVID A · 2014 to 2018
$10.8M
Plasticity of Auditory Cortical Circuits in SchizophreniaR01MH071533 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEET, ROBERT A · 2004 to 2018
$6.9M
Deciphering the GABA neuron alterations in schizophreniaR01MH119701 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FISH, KENNETH N · 2019 to 2023
$2.2M
NIMH NIH HHS 071533NIMH NIH HHS 103204NIMH NIH HHS P50 MH103204NIMH NIH HHS R01 MH071533NIMH NIH HHS R01 MH119701
6 · The paper itself

Abstract

Alterations in cannabinoid CB1 receptor (CB1R) are implicated in various psychiatric disorders. CB1R participates in both depolarization induced suppression of inhibition (DSI) and depolarization induced suppression of excitation (DSE), suggesting its involvement in regulating excitatory and inhibitory (E/I) balance. Prior studies examining neuronal cell type specific CB1R distribution have been conducted near exclusively within rodents. Identification of these distribution patterns within the human and non-human primate cortex is essential to increase our insight into its function. Using co-labeling immunohistochemistry and fluorescent microscopy, we examined CB1R protein levels within excitatory and inhibitory boutons of male human and non-human primate prefrontal cortex and auditory cortices, regions involved in the behavioral effects of exogenous cannabinoid exposures. We found that CB1R was present in both bouton populations within all brain regions examined in both species. Significantly higher CB1R levels were found within inhibitory than within excitatory boutons across all regions in both species, although the cell type by brain region interactions differed between the two species. Our results support the importance of conducting more in-depth CB1R examinations to understand how cell type and brain region dependent differences contribute to regional E/I balance regulation, and how aberrations in CB1R distribution may contribute to pathology.

Indexed as

CannabinoidsAnimalsHumansMaleNeuronsPrefrontal CortexPrimatesReceptor, Cannabinoid, CB1CannabinoidsReceptor, Cannabinoid, CB1

Identifiers

PMID35688916
PMCPMC9187707
OpenAlexW4281684415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.